Generate Biomedicines has filed for an IPO on the Nasdaq, seeking to raise upwards of $100 million for its AI-powered drug discovery operations. Incubated by Flagship Pioneering, Generate applies AI ...
21h
Y Combinator-backed Random Labs launches Slate V1, claiming the first 'swarm-native' coding agent
When a worker thread completes a task, it doesn't return a sprawling transcript of every failed attempt; it returns a compressed summary of the successful tool calls and conclusions.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results